Gambia tightens quality checks on medicines from India
Gamia's drug regulator introduces regulation of pre-shipment document verification, physical inspection, quality control testing, issuance of CRIA for pharmaceuticals
gambia
June 2023
May 2023
January 2023
December 2022
October 2022
Gambia cough syrup deaths: US FDA issues advisory to drug makers
Advisory comes after deaths were reported from Uzbekistan, Gambia after kids consumed cough syrups with high levels of diethylene glycol and ethylene glycol supplied by Indian manufacturers
Amid Gambia row, Maiden Pharma’s HP plant cough syrups flagged ‘spurious’
CDSCO in its December 2022 alert says five cough syrup samples produced by Maiden at its Baddi plant are "not of standard quality".
India's drug regulator probing Uzbekistan cough syrup death allegations
CDSCO along with UP Drug Control Administration had carried out a joint inspection of Marion's Noida facility, says health minister Mansukh Mandaviya.
Uzbekistan blames India's Marion Biotech cough syrup for 18 child deaths
Uzbekistan is the second country after Gambia to link child deaths to India made cough syrups.
The Gambian deadlock: India's drug authority rejects Gambia panel's claim of child deaths from Maiden Pharma drug
The Drugs Controller General of India (DCGI) has ruled out contamination possibilities in the four products Maiden Pharma supplied to Gambia.
Probe begins after WHO issues alert for Made in India cough syrup
Maiden Pharmaceutical holds manufacturing permission for these products for export only, the government says.
